Baatz, F., Ghosh, A., Herbst, J., Polten, S., Meyer, J., Rhiel, M., . . . Sauer, M. G. (2025). Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity. Molecular Therapy, 33(4), 1584-1607. https://doi.org/10.1016/j.ymthe.2025.02.024

Baatz, Franziska, et al. "Targeting BCL11B in CAR-engineered Lymphoid Progenitors Drives NK-like Cell Development with Prolonged Anti-leukemic Activity." Molecular Therapy 33, no. 4 (2025): 1584-1607. https://doi.org/10.1016/j.ymthe.2025.02.024.

Baatz, Franziska, et al. "Targeting BCL11B in CAR-engineered Lymphoid Progenitors Drives NK-like Cell Development with Prolonged Anti-leukemic Activity." Molecular Therapy, vol. 33, no. 4, 2025, pp. 1584-1607, https://doi.org/10.1016/j.ymthe.2025.02.024.